Usage: ACULAR® ophthalmic solution is indicated for temporary relief of ocular itching from seasonal allergic conjunctivitis and for treating postoperative inflammation following cataract extraction.
Usage: Bromfenac ophthalmic solution 0.075% is indicated for treating postoperative inflammation and preventing ocular pain in patients following cataract surgery.
Usage: Bromfenac ophthalmic solution, 0.07% is indicated for treating postoperative inflammation and reducing ocular pain in patients following cataract surgery.
Usage: Bromfenac ophthalmic solution, 0.075%, is indicated for treating postoperative inflammation and preventing ocular pain in patients who have undergone cataract surgery.
Usage: Bromfenac Ophthalmic Solution 0.07% is indicated for treating postoperative inflammation and reducing ocular pain in patients following cataract surgery.
Usage: Bromfenac Ophthalmic Solution 0.07% is indicated for treating postoperative inflammation and reducing ocular pain in patients following cataract surgery.
Usage: This drug is indicated for various conditions, including endocrine and rheumatic disorders, collagen diseases, severe allergic states, ophthalmic and respiratory diseases, hematologic disorders, neoplastic diseases, edematous states, gastrointestinal diseases, and certain miscellaneous conditions, as well as for diagnostic testing of adrenocortical hyperfunction.
Usage: This drug is indicated for various conditions, including adrenal insufficiencies, rheumatic disorders, collagen diseases, severe allergic reactions, ophthalmic, gastrointestinal, respiratory, hematologic, and neoplastic diseases, and for reducing edema. It can be administered intravenously, intramuscularly, intra-articularly, or intralesionally, depending on the condition.
Usage: This drug is indicated for various conditions, including endocrine disorders (like adrenocortical insufficiency), rheumatic and collagen diseases, severe allergic reactions, dermatologic and gastrointestinal diseases, respiratory issues, hematologic conditions, neoplastic diseases, and neurological disorders. It can be administered intravenously, intramuscularly, intra-articularly, or intralesionally as appropriate.